Multiple sclerosis-associated uveitis in Persian population, a multicenter study.
Anvari P, Fekri S, Hedayatfar A, Heidari H, Hosseini S, Khamesi S, Kohandel K, Mahdizad Z, Soheilian M, Zarei M, Niktinat H, Ebrahimiadib N.
Mult Scler Relat Disord. 2024 Dec;92:105947. doi: 10.1016/j.msard.2024.105947. Epub 2024 Oct 20.
PMID:39476562
Multiple sclerosis-associated uveitis successfully controlled with ofatumumab.
Azargui S, Xia JL, McClain IJ, Dacey M, Wolf AB, Palestine AG, Reddy AK.
J Ophthalmic Inflamm Infect. 2025 Nov 14;15(1):84. doi: 10.1186/s12348-025-00543-0.
PMID:41239063
Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
Saboya-Galindo P, Mejía-Salgado G, Cifuentes-González C, Rodríguez-Rodríguez CA, Boada-Robayo L, Méndez-Marulanda R, Varela JS, Riveros-Sierra L, Gaviria-Carrillo M, de-la-Torre A.
PLoS One. 2024 Oct 25;19(10):e0307455. doi: 10.1371/journal.pone.0307455. eCollection 2024.
PMID:39453915
Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.
Standardization of Uveitis Nomenclature (SUN) Working Group.
Am J Ophthalmol. 2021 Aug;228:72-79. doi: 10.1016/j.ajo.2021.03.044. Epub 2021 May 11.
PMID:33845022
Prognosis of patients with multiple sclerosis associated with uveitis.
Martin M, Vidal JS, Papeix C, Roux T, Bodini B, Louapre C, Touitou V, Maillart E.
Mult Scler Relat Disord. 2023 Oct 20;80:105095. doi: 10.1016/j.msard.2023.105095. Online ahead of print.
PMID:39491078
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series.
Stascheit F, Rübsam A, Otto C, Meisel A, Ruprecht K, Pleyer U.